The association between proton pump inhibitor use and the risk of tuberculosis: A case‐control study

Few studies have reported an association between proton pump inhibitor (PPI) use and tuberculosis. Tuberculosis incidence is relatively high in Asian people, and an increase in PPI prescriptions has been reported in South Korea. Thus, we investigated the association between PPI use and tuberculosis development.

• Publication year

  2019

• Venue

  Pharmacoepidemiology and Drug Safety

• Publication date

  2019-03-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pds.4773PMID 30920070
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Prevalence and Features of Alcohol Use during Pregnancy in South Korea based on the Nationwide Data from the Health Insurance Review and Assessment Service

  2018cited by this paper
• Tuberculosis prevention and care in Korea: Evolution of policy and practice

  2018cited by this paper
• Trends in Infectious Disease Mortality, South Korea, 1983–2015

  2018cited by this paper
• The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis

  2018cited by this paper
• Cohort Profile Cohort Profile : The National Health Insurance Service – National Sample Cohort ( NHIS-NSC ) , South Korea

  2017cited by this paper
• Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan

  2017cited by this paper
• An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma

  2017cited by this paper
• Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015

  2017cited by this paper
• Dementia, cognitive impairment and proton pump inhibitor therapy: A systematic review

  2017cited by this paper
• Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis

  2017cited by this paper
• Increased risk of pulmonary tuberculosis in patients with gastroesophageal reflux disease.

  2016cited by this paper
• Global epidemiology of tuberculosis.

  2015cited by this paper
• Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis

  2015cited by this paper
• Achievements in and Challenges of Tuberculosis Control in South Korea

  2015cited by this paper
• A Study on the Relapse Rate of Tuberculosis and Related Factors in Korea Using Nationwide Tuberculosis Notification Data

  2014cited by this paper
• Acid suppressive agents and risk of Mycobacterium Tuberculosis: case–control study

  2014cited by this paper
• Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis

  2013cited by this paper
• Gastrointestinal tuberculosis is not associated with proton pump inhibitors: a retrospective cohort study.

  2013cited by this paper
• Prevalence of gastroesophageal reflux disease in Korea and associated health‐care utilization: A national population‐based study

  2012cited by this paper
• Overutilization of proton-pump inhibitors: what the clinician needs to know

  2012cited by this paper
• An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

  2011cited by this paper
• Matching methods for causal inference: A review and a look forward.

  2010cited by this paper
• Safety of the long-term use of proton pump inhibitors.

  2010cited by this paper
• Risk factors associated with recent transmission of tuberculosis: systematic review and meta-analysis.

  2009cited by this paper
• Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids

  2007cited by this paper
• Mycobacterium tuberculosis in Taiwan.

  2006cited by this paper
• Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.

  2004cited by this paper
• Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs.

  2004cited by this paper
• Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity*

  2002cited by this paper
• Adverse drug reactions: definitions, diagnosis, and management.

  2000cited by this paper
• Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control.

  2000cited by this paper
• Hypochlorhydria induced by a proton pump inhibitor leads to intragastric microbial production of acetaldehyde from ethanol

  2000cited by this paper
• A new mechanism for anti‐inflammatory actions of proton pump inhibitors – inhibitory effects on neutrophil–endothelial cell interactions

  2000cited by this paper
• Acid suppression: optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome.

  2000cited by this paper
• The global burden of tuberculosis.

  1999cited by this paper
• Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study.

  1996cited by this paper
• Activity Inhibition of Cytolytic Lymphocytes by Omeprazole

  1996cited by this paper
• The effect of omeprazole on human natural killer cell activity.

  1995cited by this paper

• Association of acid-suppressive therapy and tuberculosis: A causal or coincidental link to the infection?

  2024cites this paper
• The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance

  2023cites this paper
• Association between pulmonary tuberculosis and acid suppressive agents

  2019cites this paper